Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Pliant Therapeutics, Inc. (PLRX) had Operating Cash Flow per Share of $-1.46 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-43.30M |
|
-- |
|
-- |
|
$45.59M |
|
$-45.59M |
|
$2.29M |
|
$-43.30M |
|
$-43.30M |
|
$-43.30M |
|
$-43.30M |
|
$-43.30M |
|
$-43.30M |
|
$-45.59M |
|
$-43.17M |
|
61.39M |
|
61.39M |
|
$-0.71 |
|
$-0.71 |
|
| Balance Sheet Financials | |
$267.44M |
|
$4.89M |
|
$32.38M |
|
$299.82M |
|
$20.59M |
|
$30.36M |
|
$59.15M |
|
$79.74M |
|
$220.08M |
|
$220.08M |
|
$220.08M |
|
61.39M |
|
| Cash Flow Statement Financials | |
$-89.47M |
|
$104.60M |
|
$0.50M |
|
$72.67M |
|
$88.30M |
|
$15.63M |
|
$15.29M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.99 |
|
-- |
|
-- |
|
0.12 |
|
0.14 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-89.84M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-19.67% |
|
-19.67% |
|
-14.44% |
|
-17.29% |
|
$3.59 |
|
$-1.46 |
|
|
Operating Cash Flow per Share |
$-1.46 |